Global Scans · Sleep · Weekly Summary

• [New] Nearly 38% of adults in the United States are at an increased risk for sleep apnea, driving consistent demand for non-invasive devices. Market Data Forecast
• [New] The global sleep tourism sector is worth more than $690 billion and is projected to grow by another $400 billion between 2024 and 2028. Yahoo Travel
• Poor sleep health is a major risk factor for lower well-being across multiple areas of life. Yahoo Travel
• In the clinical trial, sleep experts at UCSF will apply a four-session intervention that has been demonstrated to be effective in individuals with established post-traumatic stress but never in people who are in the early aftermath of trauma. Newsroom
• Sleep problems are an important risk factor for post-traumatic stress and other adverse health problems. Newsroom
• Russian low-level space warfare in the coming decades will employ maneuvering robot satellites, mobile jammers and hidden sleeper satellites that activate at unexpected times. The Washington Times
• With a staggering nine in ten Japanese consumers reporting stress, there's a dynamic opportunity for RTD teas that target fatigue, sleep and relaxation. Mintel
• If implemented responsibly, AI-powered sleep technologies could play a significant role in addressing the global sleep crisis and improving long-term health outcomes. Global Wellness Institute
• Currently, 36.3% of U.S. adults report short sleep duration, which is now recognized as a major cardiovascular risk factor. United Diagnostic Services LLC
• New research digs into why US courts need to recognize the risks of trusting sleep-deprived statements and confessions. Futurity
• The ACCC will prioritise product safety issues for young children, with a focus on compliance with button battery, infant sleep and toppling furniture mandatory standards. National Law Review
• By 2030, Lilly aims to have a portfolio that treats obesity, Alzheimer's, and sleep disorders with a precision that was unthinkable a decade ago. Simply Wall St
• People on Medicare can get GLP-1s covered by Part D plans only if they are used for a medically accepted FDA-approved indication other than obesity, like type 2 diabetes, cardiovascular disease risk reduction, or sleep apnea. KFF
• By late 2026, having an AI that acts independently while you sleep will be normal, not cutting-edge. rivva blog
• Australian companies pioneering remote control centers found that employees operating equipment by screen faced new strains, longer hours, sleep disruptions, and a sense of isolation that led to burnout for some. Highways Today

Last updated: 01 June 2026